Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

While Catharine Krebs was working in a human-genetics laboratory during her PhD at the University of California, Los Angeles, there was a line that she got used to seeing at the end of papers: “These ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

LaBonne is president of the Society for Developmental Biology and the Erastus Otis Haven professor of molecular biosciences at Northwestern University. Imagine a world without lifesaving medicines, ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

A recent op-ed in The Hill praising the National Institutes of Health’s new initiative to promote human-based technologies as a “major victory for animal ethics in science” oversimplifies a far more ...

There are a lot of hot-button questions when it comes to the ethics of scientific research, but the perennial issue of animal testing seems to incite fever-pitched anger on both side of the debate.

A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on studies with animals and cells. It also highlights the benefits of these ...